SoylentNews is people
SoylentNews
Submitted via IRC for SoyCow1984
Drug companies are sitting on generics—43% of recently approved aren't for sale
Of the more than 1,600 generic drugs approved by the Food and Drug Administration since January of 2017, more than 700—or 43 percent—are not for sale in the US, according to a new analysis by Kaiser Health News.
The finding means that many pricy, brand-name drugs are not facing the competition that could help drive down soaring prices. Among the drugs missing in action are generic versions of the expensive blood thinner Brilinta and the HIV medication Truvada. Moreover, of the approved drugs that would offer a brand-name drug its first competition, 36 percent are being held off the market, the analysis found.
This discussion has been archived.
No new comments can be posted.
Drug Companies are Sitting on Generics—43% of Recently Approved Aren’t for Sale
|
Log In/Create an Account
| Top
| 48 comments
| Search Discussion
The Fine Print: The following comments are owned by whoever posted them. We are not responsible for them in any way.
And tomorrow will be like today, only more so.
-- Isaiah 56:12, New Standard Version
(Score: 0) by Anonymous Coward on Sunday February 10 2019, @10:04PM (2 children)
And now they (government) will "legalize" weed which makes it 10x more expensive (watch the "murder mountain" documentary).
(Score: 2, Informative) by Anonymous Coward on Sunday February 10 2019, @11:12PM (1 child)
Grow yer own, even a shitty grower will get enough usable weed.
(Score: 2) by dry on Monday February 11 2019, @02:19AM
You need somewhere to grow. Most landlords won't allow it, same with condo associations.